Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 AUG 24 ... of air passages within the lungs. Some of the cultures had been pretreated with an aldose reductase inhibitor, while others had not. The untreated cells responded in much the same way ...
Subject: University of Texas Medical Branch at Galveston
2009 MAY 11 ... at baseline with those measured after a 3-month course of epalrestat (150 mg/day), an aldose reductase inhibitor. While administration of epalrestat did not result in significant changes in plasma ...
2009 MAR 23 ... Experimental Therapeutics (Regulation of Plasma Fructose and Mortality in Mice by the Aldose Reductase Inhibitor Lidorestat. Journal of Pharmacology and Experimental Therapeutics, ...
2009 SEP 14 ... "The charge density and the topological features of fidarestat, an inhibitor of human aldosereductase, have been determined from ultra high-resolution X-ray diffraction data at 100 ...
2009 APR 6 ... "Aldosereductase (ALR2) belongs to the aldo-keto reductase ( AKR) superfamily of enzymes, is ... acid (DCL) were used to determine the type of inhibition, and correlate inhibitor potency and binding energies of the complexes with ALR2 and the homologous aldehyde ...
2009 MAY 11 ... chemokine CCL2, osteopontin, fibronectin, decorin, plasminogen activator inhibitor 1 and aldosereductase. Identifying the molecular mechanisms by which diabetic nephropathy occurs has ...
2009 JAN 26 ... New investigation results, 'Aldosereductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor ... This decrease in unprocessed TNF-alpha was prevented by the aldose reductase (AR) inhibitor sorbinil and AR small interference RNA. Treatment with HG, but not equimolar mannitol or ...
2009 JUL 27 ... or cataract. Catalyzing the NADPH-dependent reduction of glucose to sorbitol, aldosereductase (ALR2) is an important target in the prevention of these complications. The ... approach. A virtual screening based on the ultrahigh-resolution crystal structure of the inhibitor IDD 594 in complex with human ALR2 identified two compounds with IC50 values in the low ...
2009 MAY 18 ... Current study results from the report, 'Aldosereductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic ... colon cancer mice model. Male BALB/c mice were administrated with AOM without or with AR inhibitor, sorbinil and at the end of the protocol, all the mice were euthanized and colons were ...
2009 MAR 2 ... Current study results from the report, 'The effect of aldosereductase inhibition by JMC-2004 on hyperglycemia-induced endothelial dysfunction,' ... Czech Republic report.
"In this study, the effect of a novel ALR-2 inhibitor JMC-2004 on hyperglycemia-induced endothelial dysfunction was studied. Bovine aortic ...
2009 AUG 24 ... diabetes and compared it with that of control rats. We then tested whether the aldose reductase inhibitor sorbinil and aspirin, which have different mechanisms of action, prevented common ...
2009 JUN 29 ... W. EGF receptor signaling is involved in expression of osmoprotective TonEBP target gene aldosereductase under hypertonic conditions. Am J Physiol Renal Physiol 296: F1100-F1108, ... high NaCl in Madin-Darby canine kidney (MDCK) cells. Conversely, the broad-spectrum MMP inhibitor GM6001 or the EGFR inhibitor AG1478 diminished phosphorylation of EGFR, p38, and ERK1/2, ...
2009 NOV 2 ... "Diabetes is one of the major risk factors for cataract. Aldosereductase has been reported to play an important role in sugar-induced cataract," ... The researchers concluded: "Among these, 4 was found to be the most potent RLAR inhibitor (IC50 = 0.23 mu g/mL), and may be useful in the prevention and/or treatment of diabetic ...
2009 OCT 5 ... investigated animal models for diabetic retinopathy (DR) are the rat and dog. In dogs, aldosereductase (AR) is present only in retinal capillary pericytes and their destruction has ... 50 mM glucose or galactose with/without the AR inhibitors or a sorbitol dehydrogenase inhibitor (SDI) or with 30 mM 3-fluoro-3-deoxyglucose. Polyol levels were determined by HPLC or ...
2008 NOV 10 ... New research, 'Nrf2 regulates curcumin-induced aldosereductase expression indirectly via nuclear factor-kappaB,' is the subject of a report. ... manner."
"Small interfering RNA (siRNA) against p65 or BAY11-7082, an inhibitor of NF-kappaB, significantly suppressed the curcumin and/or Nrf2-induced increase in ...
2008 SEP 22 ... an initial deficit in the early stage of diabetic retinopathy. The preventive effect of aldosereductase ( AR) inhibitor (ARI) for high glucose-induced pericyte loss and EC growth was ...
2008 SEP 8 ... report, 'Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldosereductase and generation of advanced glycation endproducts,' have been published. ... IC50 0.37 microM), showed significant inhibitory activities compared with the potent AR inhibitor epalrestat (IC50 0.28 microM)," wrote H.A. Jung and colleagues, Pukyong National ...
2008 AUG 25 ... According to a study from Nagoya, Japan, " The long-term efficacy of epalrestat, an aldose reductase inhibitor, in improving subjective symptoms and nerve function was comprehensively assessed to ...
2008 AUG 25 ... publish new data in the report 'Long-term treatment with ranirestat (AS-3201), a potent aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats.' According to recent ...
